WA People
BILL · 2023–24 SESSION

HB 1269: Rx drug affordability board

Amending the prescription drug affordability board.

Summary

  • Removes the limits on the types of drugs that are eligible for review provided that benchmark criteria are met.
  • Makes changes to prescription drug threshold prices and percentage increases on prices that trigger eligibility for review.
  • Advances the date that the Prescription Drug Affordability Board is authorized to begin establishing upper payment limits by one year, to January 1, 2026, except for prescription drugs used solely for the treatment of a rare disease or condition.
  • Eliminates references to required delays in the adoption of rules upper payment limits.

From the House Bill Report (HB 1269), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 12, 2023
  2. Out of committeeFeb 14, 2023
  3. Passed Housestopped here
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Marcus Riccelli (D-3)
Introduced
January 12, 2023 in the House
Last action
January 8, 2024
Requested by
Other
Budget
Has a fiscal note

AN ACT Relating to amending the prescription drug affordability board;

Sponsors

Prime sponsor: Marcus Riccelli (D-3)

2 co-sponsors (2 Democrats, 0 Republicans)

Monica Jurado Stonier D-49Nicole Macri D-43

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. Referred to Health Care & Wellness.
  2. Rules Committee relieved of further consideration.
  3. By resolution, reintroduced and retained in present status.
  4. Referred to Rules 2 Review.
  5. HCW - Executive action taken by committee.
  6. Minority; without recommendation.
  7. Minority; do not pass.
  8. HCW - Majority; do pass.
  9. First reading, referred to Health Care & Wellness.

HB 1269 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page